Table 2.
F2-isoprostane Concentrations in Patients with RA According to Categorical Demographic and Clinical Characteristics
| VARIABLE | n | F2- isoprostane | P value* |
|---|---|---|---|
| Gender | 0.006 | ||
| Male | 52 | 2.06 [1.56-3.11] | |
| Female | 117 | 3.23 [1.85-4.54] | |
| Current Smoking | <0.001 | ||
| Yes | 41 | 3.58 [2.85-5.01] | |
| No | 128 | 2.44 [1.52-3.75] | |
| Hypertension | 0.22 | ||
| Yes | 90 | 1.42 [2.58-4.07] | |
| No | 79 | 1.78 [3.02-4.01] | |
| Diabetes Mellitus | 0.72 | ||
| Yes | 19 | 2.28 [1.68-4.00] | |
| No | 150 | 2.81 [1.61-4.06] | |
| Current Corticosteroids | 0.75 | ||
| Yes | 92 | 2.76 [1.71-4.03] | |
| No | 77 | 2.72 [1.50-4.31] | |
| Current Methotrexate | 0.96 | ||
| Yes | 120 | 2.74 [1.60-4.00] | |
| No | 49 | 2.81 [1.63-4.21] | |
| Current Antimalarials | 0.87 | ||
| Yes | 127 | 2.79[1.54-4.07] | |
| No | 42 | 2.75[1.67-4.05] | |
| Current anti-TNF | 0.25 | ||
| Yes | 35 | 3.19 [2.12-3.98] | |
| No | 134 | 2.72 [1.55-4.06] | |
| Current Statin | |||
| Yes | 21 | 2.24 [1.56-3.38] | 0.14 |
| No | 148 | 2.88 [1.62-4.20] |
Wilcoxon rank-sum test.